{"id":"https://openalex.org/W2117467553","doi":"https://doi.org/10.3960/jslrt.52.211","title":"Epstein-Barr Virus-Negative, CD5-Positive Diffuse Large B-Cell Lymphoma Developing after Treatment with Oral Tacrolimus for Mixed Connective Tissue Disease : A Case Report and Review of the Literature","display_name":"Epstein-Barr Virus-Negative, CD5-Positive Diffuse Large B-Cell Lymphoma Developing after Treatment with Oral Tacrolimus for Mixed Connective Tissue Disease : A Case Report and Review of the Literature","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2117467553","doi":"https://doi.org/10.3960/jslrt.52.211","mag":"2117467553","pmid":"https://pubmed.ncbi.nlm.nih.gov/23269082"},"language":"en","primary_location":{"id":"doi:10.3960/jslrt.52.211","doi":"https://doi.org/10.3960/jslrt.52.211","is_oa":true,"landing_page_url":"https://doi.org/10.3960/jslrt.52.211","pdf_url":"https://www.jstage.jst.go.jp/article/jslrt/52/3/52_211/_pdf","source":{"id":"https://openalex.org/S2764523828","display_name":"Journal of the Japan Society of the Reticuloendothelial System","issn_l":"0386-9725","issn":["0386-9725","1342-9248","1346-4280","1880-9952","1883-6801","1883-681X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","dongbi-c","ki-jl-1","medline","oarl","poland-40","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical and Experimental Hematopathology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/jslrt/52/3/52_211/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112259359","display_name":"Yasunobu Sekiguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasunobu Sekiguchi","raw_affiliation_strings":["Division of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan. yasu_sek@juntendo-urayasu.jp","Division of Hematology, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan. yasu_sek@juntendo-urayasu.jp","institution_ids":["https://openalex.org/I4210137488"]},{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032625498","display_name":"Asami Shimada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]},{"id":"https://openalex.org/I4210145596","display_name":"Juntendo University Hospital","ror":"https://ror.org/04g0m2d49","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145596"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Asami Shimada","raw_affiliation_strings":["Division of Hematology, Juntendo University Hospital","Division of Hematology, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Hospital","institution_ids":["https://openalex.org/I4210145596"]},{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103456239","display_name":"Hidenori Imai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidenori Imai","raw_affiliation_strings":["Division of Hematology, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055784289","display_name":"Mutsumi Wakabayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mutsumi Wakabayashi","raw_affiliation_strings":["Division of Hematology, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057202650","display_name":"Keiji Sugimoto","orcid":"https://orcid.org/0000-0001-9835-5405","observed_orcids":["https://orcid.org/0000-0001-9835-5405"]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiji Sugimoto","raw_affiliation_strings":["Division of Hematology, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101465502","display_name":"Noriko Nakamura","orcid":"https://orcid.org/0000-0002-9086-2581","observed_orcids":["https://orcid.org/0000-0002-9086-2581"]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Nakamura","raw_affiliation_strings":["Division of Clinical Laboratory, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Laboratory, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002695260","display_name":"Tomonori Sawada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomonori Sawada","raw_affiliation_strings":["Division of Clinical Laboratory, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Laboratory, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031116384","display_name":"Norio Komatsu","orcid":"https://orcid.org/0000-0003-1880-9126","observed_orcids":["https://orcid.org/0000-0003-1880-9126"]},"institutions":[{"id":"https://openalex.org/I4210145596","display_name":"Juntendo University Hospital","ror":"https://ror.org/04g0m2d49","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145596"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norio Komatsu","raw_affiliation_strings":["Division of Hematology, Juntendo University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Hospital","institution_ids":["https://openalex.org/I4210145596"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048908270","display_name":"Masaaki Noguchi","orcid":"https://orcid.org/0000-0001-9458-2707","observed_orcids":["https://orcid.org/0000-0001-9458-2707"]},"institutions":[{"id":"https://openalex.org/I4210137488","display_name":"Juntendo University Urayasu Hospital","ror":"https://ror.org/03gxkq182","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137488"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaaki Noguchi","raw_affiliation_strings":["Division of Hematology, Juntendo University Urayasu Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juntendo University Urayasu Hospital","institution_ids":["https://openalex.org/I4210137488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4905,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.65166066,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"52","issue":"3","first_page":"211","last_page":"218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.6054999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.6054999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.3662000000476837,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd5-positive-lymphoma","display_name":"CD5-positive lymphoma","score":0.9139999747276306},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.972000002861023},{"id":"https://openalex.org/keywords/immunosuppressant-adverse-effects","display_name":"immunosuppressive drug adverse effects","score":0.6209999918937683},{"id":"https://openalex.org/keywords/mixed-connective-tissue-disease","display_name":"mixed connective tissue disease","score":0.8500000238418579},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9129999876022339},{"id":"https://openalex.org/keywords/sjogren-s-syndrome","display_name":"Sj\u00f6gren's syndrome","score":0.949999988079071},{"id":"https://openalex.org/keywords/central-nervous-system-invasion","display_name":"central nervous system infiltration","score":0.8989999890327454},{"id":"https://openalex.org/keywords/rituximab-based-chemotherapy","display_name":"rituximab-based chemotherapy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/relapsed-lymphoma","display_name":"relapsed lymphoma","score":0.5339999794960022},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8547540903091431},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.559236466884613},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.5463703870773315},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5060884356498718},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.47388169169425964},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.45460599660873413},{"id":"https://openalex.org/C2778818763","wikidata":"https://www.wikidata.org/wiki/Q6708226","display_name":"Lymph node biopsy","level":3,"score":0.4253942370414734},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4252732992172241},{"id":"https://openalex.org/C2776153627","wikidata":"https://www.wikidata.org/wiki/Q1622407","display_name":"Mixed connective tissue disease","level":3,"score":0.4148483872413635},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35442763566970825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3148798942565918},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.16315796971321106},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.10731169581413269}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007049","descriptor_name":"Iatrogenic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008947","descriptor_name":"Mixed Connective Tissue Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008947","descriptor_name":"Mixed Connective Tissue Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008947","descriptor_name":"Mixed Connective Tissue Disease","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008947","descriptor_name":"Mixed Connective Tissue Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012859","descriptor_name":"Sjogren's Syndrome","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018956","descriptor_name":"CD5 Antigens","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018956","descriptor_name":"CD5 Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3960/jslrt.52.211","doi":"https://doi.org/10.3960/jslrt.52.211","is_oa":true,"landing_page_url":"https://doi.org/10.3960/jslrt.52.211","pdf_url":"https://www.jstage.jst.go.jp/article/jslrt/52/3/52_211/_pdf","source":{"id":"https://openalex.org/S2764523828","display_name":"Journal of the Japan Society of the Reticuloendothelial System","issn_l":"0386-9725","issn":["0386-9725","1342-9248","1346-4280","1880-9952","1883-6801","1883-681X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","dongbi-c","ki-jl-1","medline","oarl","poland-40","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical and Experimental Hematopathology","raw_type":"journal-article"},{"id":"pmid:23269082","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23269082","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical and experimental hematopathology : JCEH","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.3960/jslrt.52.211","doi":"https://doi.org/10.3960/jslrt.52.211","is_oa":true,"landing_page_url":"https://doi.org/10.3960/jslrt.52.211","pdf_url":"https://www.jstage.jst.go.jp/article/jslrt/52/3/52_211/_pdf","source":{"id":"https://openalex.org/S2764523828","display_name":"Journal of the Japan Society of the Reticuloendothelial System","issn_l":"0386-9725","issn":["0386-9725","1342-9248","1346-4280","1880-9952","1883-6801","1883-681X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","dongbi-c","ki-jl-1","medline","oarl","poland-40","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical and Experimental Hematopathology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2117467553.pdf","grobid_xml":"https://content.openalex.org/works/W2117467553.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W73348102","https://openalex.org/W1738362696","https://openalex.org/W1990562790","https://openalex.org/W1990700995","https://openalex.org/W1994482649","https://openalex.org/W2019019272","https://openalex.org/W2050069240","https://openalex.org/W2111755272","https://openalex.org/W2112463346","https://openalex.org/W2116508491","https://openalex.org/W2124450032","https://openalex.org/W2129171694","https://openalex.org/W2131934389","https://openalex.org/W2143759877","https://openalex.org/W2413819825","https://openalex.org/W2500807402"],"related_works":["https://openalex.org/W7161276301","https://openalex.org/W4385655457","https://openalex.org/W4385070542","https://openalex.org/W4405110927","https://openalex.org/W4320856528","https://openalex.org/W1970957435","https://openalex.org/W3117982286","https://openalex.org/W3210595623","https://openalex.org/W1995867442","https://openalex.org/W2023243759"],"abstract_inverted_index":{"A":[0],"69-year-old":[1],"woman,":[2],"who":[3],"had":[4],"been":[5],"diagnosed":[6,34],"as":[7,35,86,178,216],"having":[8,36],"Sj\u00f6gren's":[9],"syndrome":[10],"at":[11,20,47,88],"37":[12],"years":[13,22],"old":[14],"and":[15,41,54,85,116,132,163,187,197,226],"mixed":[16],"connective":[17],"tissue":[18],"disease":[19],"42":[21],"old,":[23],"was":[24,33,61,79,145,170,209,219,224,228],"under":[25],"treatment":[26,44],"with":[27,45,127],"oral":[28],"prednisolone.":[29],"In":[30,50,109,150],"2009,":[31],"she":[32],"active":[37],"systemic":[38],"lupus":[39],"erythematosus,":[40],"started":[42],"on":[43],"tacrolimus":[46,223],"3":[48],"mg/day.":[49],"2010,":[51],"para-aortic":[52],"lymphadenopathy":[53,57,113],"superficial":[55],"multiple":[56,160],"were":[58],"detected.":[59],"Tacrolimus":[60],"discontinued.":[62],"Axillary":[63],"lymph":[64,103,161],"node":[65],"biopsy":[66],"revealed":[67],"Epstein-Barr":[68],"(EB)":[69],"virus-negative":[70],"CD5-positive":[71,195],"diffuse":[72],"large":[73],"B-cell":[74],"lymphoma":[75],"(DLBCL).":[76],"The":[77,168,207],"patient":[78,118,169,208],"classified":[80,177],"into":[81],"clinical":[82],"stage":[83],"IIIA":[84],"being":[87],"high":[89],"risk":[90],"according":[91],"to":[92,138,172,211],"the":[93,98,102,112,117,185,190,205],"international":[94],"prognostic":[95],"index.":[96],"After":[97],"discontinuation":[99,221],"of":[100,122,125,194,204,222,230],"tacrolimus,":[101],"nodes":[104,162],"reduced":[105],"temporarily":[106],"in":[107,159],"size.":[108],"January":[110],"2011,":[111],"increased":[114],"again,":[115],"received":[119],"a":[120,213],"total":[121],"8":[123],"courses":[124],"therapy":[126],"rituximab,":[128],"pirarubicin,":[129],"vincristine,":[130],"cyclophosphamide":[131],"prednisolone,":[133],"followed":[134,146],"by":[135,147,184],"intrathecal":[136],"injection":[137],"prevent":[139],"central":[140,164,198,231],"nervous":[141,165,199,232],"system":[142,166,200,233],"infiltration,":[143],"which":[144],"complete":[148],"remission.":[149],"February":[151],"2012,":[152],"fluorodeoxyglucose":[153],"positron":[154],"emission":[155],"tomography":[156],"showed":[157],"relapse":[158],"infiltration.":[167,234],"considered":[171,210],"have":[173,212],"iatrogenic":[174,180],"lymphoproliferative":[175,182],"disorder":[176],"\"other":[179],"immunodeficiency-associated":[181],"disorders\"":[183],"WHO,":[186],"this":[188],"is":[189],"first":[191],"reported":[192],"case":[193],"DLBCL":[196],"infiltration":[201],"following":[202],"administration":[203],"drug.":[206],"poor":[214],"prognosis":[215],"EB":[217],"virus":[218],"negative,":[220],"ineffective":[225],"there":[227],"evidence":[229]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}